ePrints@IIScePrints@IISc Home | About | Browse | Latest Additions | Advanced Search | Contact | Help

Browse by Author

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 8.

Kundu, P and Pant, I and Jain, R and Rao, SG and Kondaiah, P (2022) Genome-wide DNA methylation changes in oral submucous fibrosis. In: Oral Diseases, 28 (4). pp. 1094-1103.

Upadhyay, A and Kundu, P and Ramu, V and Kondaiah, P and Chakravarty, AR (2022) BODIPY-Tagged Platinum(II) Curcumin Complexes for Endoplasmic Reticulum-Targeted Red Light PDT. In: Inorganic Chemistry, 61 (3). pp. 1335-1348.

Ramu, V and Kundu, P and Kondaiah, P and Chakravarty, AR (2021) Maloplatin-B, a Cisplatin-Based BODIPY-Tagged Mito-Specific "chemo-PDT" Agent Active in Red Light. In: Inorganic Chemistry, 60 (9). pp. 6410-6420.

Paul, S and Kundu, P and Kondaiah, P and Chakravarty, AR (2021) BODIPY-Ruthenium(II) Bis-Terpyridine Complexes for Cellular Imaging and Type-I/-II Photodynamic Therapy. In: Inorganic Chemistry .

Ramu, V and Kundu, P and Upadhyay, A and Kondaiah, P and Chakravarty, AR (2021) Lysosome Specific Platinum(II) Catecholates with Photoactive BODIPY for Imaging and Photodynamic Therapy in Near-IR Light. In: European Journal of Inorganic Chemistry, 2021 (9). pp. 831-839.

Paul, S and Kundu, P and Bhattacharyya, U and Garai, A and Maji, RC and Kondaiah, P and Chakravarty, AR (2020) Ruthenium(II) Conjugates of Boron-Dipyrromethene and Biotin for Targeted Photodynamic Therapy in Red Light. In: Inorganic Chemistry, 59 (1). pp. 913-924.

Arora, A and Patil, V and Kundu, P and Kondaiah, P and Hegde, AS and Arivazhagan, A and Santosh, V and Pal, D and Somasundaram, K (2019) Serum biomarkers identification by iTRAQ and verification by MRM: S100A8/S100A9 levels predict tumor-stroma involvement and prognosis in Glioblastoma. In: Scientific Reports, 9 (1). p. 2749.

Arora, A and Patil, V and Kundu, P and Kondaiah, P and Hegde, AS and Arivazhagan, A and Santosh, V and Pal, D and Somasundaram, K (2019) Serum biomarkers identification by iTRAQ and verification by MRM: S100A8/S100A9 levels predict tumor-stroma involvement and prognosis in Glioblastoma. In: Scientific Reports, 9 (1).

This list was generated on Wed Jul 24 06:48:20 2024 IST.